Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018

TechNavio’s analysts forecast the Global Isothermal Nucleic Acid Amplification Technologies market will grow at a CAGR of 17.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the technological advances being made in this domain. The Global Isothermal Nucleic Acid Amplification Technologies market has also been witnessing an increase in the miniaturization of nucleic acid-based diagnostics. However, the tough competition from PCR-based diagnostics could pose a challenge to the growth of this market.
TechNavio’s report, Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA region, and the APAC region; it also covers the Global Isothermal Nucleic Acid Amplification Technologies market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space are Becton, Dickson and Co., bioMerieux S.A., Hologic Inc., Novartis International AG., and Quidel Corp.
The other vendors mentioned in the report are Alere Inc., Axxin Pvt Ltd., Eiken Chemical Co. Ltd., Great Basin Corp., Lucigen Corp., Meridian Bioscience Inc., New England Biolabs Inc., and Optigene Ltd.
Key questions answered in this report:
What will the market size be in 2018 and at what rate will it grow?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1.1 Infectious Disease Diagnostics
07.1.2 Blood Screening
07.1.3 Laboratory Research
07.1.4 Cancer Research
07.2 Global INAAT Market for Infectious Disease Diagnostics
07.2.1 Market Size and Forecast
07.3 Global INAAT Market for Blood Screening
07.3.1 Market Size and Forecast
07.4 Global INAAT Market for Laboratory Research
07.4.1 Market Size and Forecast
07.5 Global INAAT Market for Cancer Research
07.5.1 Market Size and Forecast
08. Market Segmentation by Technology
08.1.1 NASBA
08.1.2 LAMP
08.1.3 SDA
08.1.4 TMA
08.1.5 SPIA
08.1.6 HDA
08.1.7 Others
09. COMPARATIVE ANALYSIS OF TOP ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
10. Geographical Segmentation
10.1 Isothermal Nucleic Acid Amplification Technologies Market in the Americas
10.1.1 Market Size and Forecast
10.2 Isothermal Nucleic Acid Amplification Technologies Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Isothermal Nucleic Acid Amplification Technologies Market in the APAC Region
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Hologic Inc.
19.1.1 Business Overview
19.1.2 Business Segmentation
19.1.3 Key Information
19.1.4 SWOT Analysis
19.2 bioMerieux S.A.
19.2.1 Business Overview
19.2.2 Key Information
19.2.3 SWOT Analysis
19.3 Novartis International AG
19.3.1 Business Overview
19.3.2 Business Segmentation
19.3.3 Key Information
19.3.4 SWOT Analysis
19.4 Quidel Corp.
19.4.1 Business Overview
19.4.2 Key Information
19.4.3 SWOT Analysis
19.5 Becton, Dickinson and Co.
19.5.1 Business Overview
19.5.2 Business Segmentation
19.5.3 Key Information
19.5.4 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Isothermal Nucleic Acid Amplification Technologies Market 2013-2018 (US$ million)
Exhibit 3: Global Isothermal Nucleic Acid Amplification Technologies Market Segmentation by Application
Exhibit 4: Global Isothermal Nucleic Acid Amplification Technologies Market 2013 (Percentage)
Exhibit 5: Global INAAT Market for Infectious Disease Diagnostics 2013-2018 (US$ million)
Exhibit 6: Global INAAT Market for Blood Screening 2013-2018 (US$ million)
Exhibit 7: Global INAAT Market for Laboratory Research 2013-2018 (US$ million)
Exhibit 8: Global INAAT Market for Cancer Research 2013-2018 (US$ million)
Exhibit 9: Global Isothermal Nucleic Acid Amplification Technologies Market by Applications 2013-2018 (US$ million)
Exhibit 10: Global Isothermal Nucleic Acid Amplification Technologies Market by Applications 2013-2018
Exhibit 11: Global Isothermal Nucleic Acid Amplification Technologies Market Segmentation by Technology
Exhibit 12: Global Isothermal Nucleic Acid Amplification Technologies Market by Application 2013
Exhibit 13: Isothermal Nucleic Acid Amplification Technologies Market in the Americas 2013-2018 (US$ million)
Exhibit 14: Isothermal Nucleic Acid Amplification Technologies Market in the EMEA 2013-2018 (US$ million)
Exhibit 15: Isothermal Nucleic Acid Amplification Technologies Market in the APAC 2013-2018 (US$ million)
Exhibit 16: Global Isothermal Nucleic Acid Amplification Technologies Technologies by Geography 2013-2018 (US$ million)
Exhibit 17: Global Isothermal Nucleic Acid Amplification Technologies Market by Geography 2013-2018
Exhibit 18: Business Segmentation of Hologic Inc.
Exhibit 19: Business Segmentation of Novartis International AG
Exhibit 20: Business Segmentation of Becton, Dickinson and Co.